Ebola and Marburg Infections-Pipeline Insights, 2014

1
Ebola and Marburg Infections-Pipeline Insights,
2014
One-Stop Shop for Business Information
2
Summary
'Ebola and Marburg Infections-Pipeline Insights,
2014', report provides comprehensive insights
about pipeline drugs across this indication. A
key objective of the report is to establish the
understanding for all the pipeline drugs that
fall under Ebola and Marburg Infections. This
report provides information on the therapeutic
development based on the Ebola and Marburg
Infections dealing with all the pipeline drugs,
comparative analysis at various stages covering
Filed, Phase III, Phase II, Phase I, IND filed,
Preclinical, Discovery and unknown stages,
therapeutics assessment by monotherapy and
combination products and molecule type drug
information. The report also covers the companies
information involved in the therapeutic
development of the products. It also has
highlighted the discontinued and dormant products.
3
Secondary sources information and data has been
collected from various printable and
non-printable sources like search engines, News
websites, Government Websites, Trade Journals,
White papers, Magazines, Trade associations,
Books, Industry Portals, Industry Associations
and access to available databases. Scope The
report provides a snapshot of the global
therapeutic landscape of Ebola and Marburg
Infections The report provides pipeline
products under drug profile section which
includes product description, MOA, licensors
collaborators, development partner and chemical
information
4
Coverage of the Ebola and Marburg Infections
pipeline on the basis of target, MOA, route of
administration, technology involved and molecule
type The report reviews key players involved in
the therapeutics development for Ebola and
Marburg Infections and also provide company
profiling The report also gives the information
of dormant and discontinued pipeline projects 
Pipeline products coverage based on various
stages of development ranging from
preregistration till discovery and undisclosed
stages  Provides pipeline assessment by
monotherapy and combination therapy products,
stage of development and molecule type
5
- The report reviews key players involved in the
therapeutics development for Ebola Viral
Infections and enlists all their major and minor
projects- The report summarizes all the dormant
and discontinued pipeline projects - A review of
the Ebola Viral Infections products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources- Pipeline
products coverage based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages- A detailed
assessment of monotherapy and combination therapy
pipeline projects- Coverage of the Ebola Viral
Infections pipeline on the basis of target, MoA,
route of administration and molecule type-
Latest news and deals relating related to
pipeline products
6
Reasons to buy Complete Pipeline intelligence
and complete understanding over therapeutics
development for Ebola and Marburg Infections
Identify the relationship between the drugs and
use it for target finding, drug repurposing, and
precision medicine. Devise corrective measures
for pipeline projects by understanding Ebola and
Marburg Infections pipeline depth and focus of
Indication therapeutics  Developing strategic
initiatives to support your drug development
activities. Optimize your portfolio and keep
you in touch with the rapidly changing
pharmaceutical markets, and make the best
decisions for your business.
7
Develop and design in licensing and out
licensing strategies by identifying prospective
partners with the most attractive projects to
enhance and expand business potential and
scope  Provides strategically significant
competitor information, analysis, and insights to
formulate effective RD development strategies 
Modify the therapeutic portfolio by identifying
discontinued projects and understanding the
factors that drove them from pipeline Gaining a
Full Picture of the Competitive Landscape for
Evidence based Decisions
8
Table Of Content

• Ebola and Marburg Infections Overview
• Ebola and Marburg Infections Pipeline
  Therapeutics
• Ebola and Marburg Infections Therapeutics under
  Development by Companies
• Ebola and Marburg Infections Late Stage Products
  (Filed and Phase III)
• Comparative Analysis
• Ebola and Marburg Infections Mid Clinical Stage
  Products (Phase II)
• Comparative Analysis
• Ebola and Marburg Infections Early Clinical
  Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Ebola and Marburg Infections Discovery and
  Pre-Clinical Stage Products

9

• To know more
• Ebola and Marburg Infections-Pipeline Insights,
  2014

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com